Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Hagedoorn

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Journal of Aerosol Medicine and Pulmonary Drug Delivery|June 23, 2026
Usability of Levodopa Cyclops<sup>®</sup> Compared to INBRIJA<sup>®</sup> During an off Episode in Parkinson's Disease PatientsValesca Wangsawirana, Lara de Jong, Annebet van der Meulen, et al.
Plos One|June 6, 2014
Effect of inhaler design variables on paediatric use of dry powder inhalersAnne J Lexmond, Tonnis J Kruizinga, Paul Hagedoorn, et al.
Respiratory Medicine|March 10, 2009
Comparative in vitro evaluation of four corticosteroid metered dose inhalers: Consistency of delivered dose and particle size distributionTjalling W de Vries, Bart L Rottier, Doetie Gjaltema, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|October 22, 2013
Adenosine dry powder inhalation for bronchial challenge testing, part 1: inhaler and formulation development and in vitro performance testingAnne J Lexmond, Paul Hagedoorn, Erica van der Wiel, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 3, 2006
Design and in vitro performance testing of multiple air classifier technology in a new disposable inhaler concept (Twincer) for high powder dosesAnne H de Boer, Paul Hagedoorn, Elsbeth M Westerman, et al.
Plos One|February 4, 2014
New mechanisms to explain the effects of added lactose fines on the dispersion performance of adhesive mixtures for inhalationFloris Grasmeijer, Anne J Lexmond, Maarten van den Noort, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 1, 2014
Adenosine dry powder inhalation for bronchial challenge testing, part 2: proof of concept in asthmatic subjectsAnne J Lexmond, Erica van der Wiel, Paul Hagedoorn, et al.
BMJ Open|June 14, 2022
Turning green: the impact of changing to more eco-friendly respiratory healthcare - a carbon and cost analysis of Dutch prescription dataPieter Ten Have, Peter van Hal, Iris Wichers, et al.
Acta Pharmaceutica Sinica. B|December 24, 2019
Pulmonary immunization: deposition site is of minor relevance for influenza vaccination but deep lung deposition is crucial for hepatitis B vaccinationJasmine Tomar, Wouter F Tonnis, Harshad P Patil, et al.
Expert Opinion on Drug Metabolism & Toxicology|November 20, 2020
The pharmacokinetics of antibiotics in cystic fibrosisAnne M Akkerman-Nijland, Onno W Akkerman, Floris Grasmeijer, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Journal of Aerosol Medicine and Pulmonary Drug Delivery|June 23, 2026
Usability of Levodopa Cyclops<sup>®</sup> Compared to INBRIJA<sup>®</sup> During an off Episode in Parkinson's Disease PatientsValesca Wangsawirana, Lara de Jong, Annebet van der Meulen, et al.
Plos One|June 6, 2014
Effect of inhaler design variables on paediatric use of dry powder inhalersAnne J Lexmond, Tonnis J Kruizinga, Paul Hagedoorn, et al.
Respiratory Medicine|March 10, 2009
Comparative in vitro evaluation of four corticosteroid metered dose inhalers: Consistency of delivered dose and particle size distributionTjalling W de Vries, Bart L Rottier, Doetie Gjaltema, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|October 22, 2013
Adenosine dry powder inhalation for bronchial challenge testing, part 1: inhaler and formulation development and in vitro performance testingAnne J Lexmond, Paul Hagedoorn, Erica van der Wiel, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 3, 2006
Design and in vitro performance testing of multiple air classifier technology in a new disposable inhaler concept (Twincer) for high powder dosesAnne H de Boer, Paul Hagedoorn, Elsbeth M Westerman, et al.
Plos One|February 4, 2014
New mechanisms to explain the effects of added lactose fines on the dispersion performance of adhesive mixtures for inhalationFloris Grasmeijer, Anne J Lexmond, Maarten van den Noort, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 1, 2014
Adenosine dry powder inhalation for bronchial challenge testing, part 2: proof of concept in asthmatic subjectsAnne J Lexmond, Erica van der Wiel, Paul Hagedoorn, et al.
BMJ Open|June 14, 2022
Turning green: the impact of changing to more eco-friendly respiratory healthcare - a carbon and cost analysis of Dutch prescription dataPieter Ten Have, Peter van Hal, Iris Wichers, et al.
Acta Pharmaceutica Sinica. B|December 24, 2019
Pulmonary immunization: deposition site is of minor relevance for influenza vaccination but deep lung deposition is crucial for hepatitis B vaccinationJasmine Tomar, Wouter F Tonnis, Harshad P Patil, et al.
Expert Opinion on Drug Metabolism & Toxicology|November 20, 2020
The pharmacokinetics of antibiotics in cystic fibrosisAnne M Akkerman-Nijland, Onno W Akkerman, Floris Grasmeijer, et al.
Pageof 5